Menu
1. Lung cancer
2. Cancer : types and impact
3. Incidence raising, mortality reducing
4. Causes and Risk factors for Lung Cancer
5. Types of Lung Cancer
6. NSCLC Histology
7. NSCLC Survival State of the Art 2003
8. Staging/Diagnostic Tests
9. Lung Tumor Board
10. Progress in lung treatment
11. Personalized Cancer Therapy
12. Diagnostic Moléculaire complémentaire
13. Target therapies
14. NSCLC EGFR
15. IPASS study
16. Treatment algorithm 2019
17. Immunotherapy targets in NSCLC: CTLA-4 and PD-1 pathways
18. CheckMate 017
19. CheckMate 057
20. Nivolumab in previously treated patients: 5 year survival data
21. Pembrolizumab as first-line treatment of advanced NSCLC: KEYNOTE-024
22. Patients with PDL1 > 50%:keynote 024
23. Long term control in highly selected patients
24. Clinical practice guidelines
25. Clinical practice guidelines
26. ESMO
27. Immune check points modulators
28. Merci
Lung Cancer, Dr Alfredo Addeo, 23.07.19
Resources
Here are some useful links and documents:
Title
Title
Title
FINISH
SUBMIT
NEXT
PREV
Submit All
